Version 1
: Received: 27 June 2024 / Approved: 1 July 2024 / Online: 5 July 2024 (09:17:29 CEST)
How to cite:
Khalid, A.; Wons, M.; Vaghela, A.; Hollar, S.; Mack, J.; Evans, H.; Snyder, J.; Brooks, B. A Retrospective Cross-Sectional Analysis of Self-Reported Adverse Events Following Immunization with the Shingrix Vaccine . Preprints2024, 2024070502. https://doi.org/10.20944/preprints202407.0502.v1
Khalid, A.; Wons, M.; Vaghela, A.; Hollar, S.; Mack, J.; Evans, H.; Snyder, J.; Brooks, B. A Retrospective Cross-Sectional Analysis of Self-Reported Adverse Events Following Immunization with the Shingrix Vaccine . Preprints 2024, 2024070502. https://doi.org/10.20944/preprints202407.0502.v1
Khalid, A.; Wons, M.; Vaghela, A.; Hollar, S.; Mack, J.; Evans, H.; Snyder, J.; Brooks, B. A Retrospective Cross-Sectional Analysis of Self-Reported Adverse Events Following Immunization with the Shingrix Vaccine . Preprints2024, 2024070502. https://doi.org/10.20944/preprints202407.0502.v1
APA Style
Khalid, A., Wons, M., Vaghela, A., Hollar, S., Mack, J., Evans, H., Snyder, J., & Brooks, B. (2024). <span data-contrast="none">A Retrospective Cross-Sectional Analysis of Self-Reported Adverse Events Following Immunization with the Shingrix Vaccine <span data-ccp-props="{"201341983":2,"335559739":240,"335559740":240}">. Preprints. https://doi.org/10.20944/preprints202407.0502.v1
Chicago/Turabian Style
Khalid, A., Jerold Snyder and Benjamin Brooks. 2024 "<span data-contrast="none">A Retrospective Cross-Sectional Analysis of Self-Reported Adverse Events Following Immunization with the Shingrix Vaccine <span data-ccp-props="{"201341983":2,"335559739":240,"335559740":240}">" Preprints. https://doi.org/10.20944/preprints202407.0502.v1
Abstract
This paper investigates the safety profile of the Shingrix vaccine, focusing particularly on persistent adverse events post-vaccination. Shingrix, crucial for preventing shingles caused by the varicella-zoster virus, has shown efficacy in clinical trials but is associated with varying degrees of adverse reactions. This retrospective, cross-sectional survey-based study, spanning two years and involving 77 respondents who experienced severe adverse events after vaccination, reveals a spectrum of symptoms ranging from mild to severe, including reports of Guillain-Barré syndrome and neuropathy. These findings underscore the need for ongoing vigilance in vaccine safety monitoring and highlight the importance of personalized care approaches for managing post-vaccination adverse effects. The study aims to contribute to informed decision-making regarding shingles vaccination strategies and calls for continued research into the long-term safety and efficacy of Shingrix.
Medicine and Pharmacology, Medicine and Pharmacology
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
